Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7189 | 1395 | 40.4 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
113 | 3 | EDUCATION, SPECIAL//REHABILITATION//AUTISM | 70772 |
493 | 2 | AUTISM//JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS//AUTISM SPECTRUM DISORDER | 15418 |
7189 | 1 | CHRISTIAN SARKINE AUTISM TREATMENT//NISONGER//NISONGER MENTAL RETARDAT DEV DISABIL | 1395 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CHRISTIAN SARKINE AUTISM TREATMENT | address | 246903 | 1% | 59% | 19 |
2 | NISONGER | address | 168073 | 3% | 20% | 39 |
3 | NISONGER MENTAL RETARDAT DEV DISABIL | address | 131325 | 0% | 100% | 6 |
4 | JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | journal | 130593 | 6% | 7% | 87 |
5 | PERVASIVE DEVELOPMENTAL DISORDER | authKW | 112238 | 4% | 9% | 57 |
6 | MEDS | authKW | 100050 | 1% | 57% | 8 |
7 | NISONGER UCEDD | address | 88634 | 1% | 45% | 9 |
8 | PSYCHOTROPIC MEDICATION | authKW | 86369 | 2% | 14% | 29 |
9 | AUTISM | authKW | 76857 | 14% | 2% | 190 |
10 | MERCK PROGRAM | address | 70038 | 0% | 80% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Education, Special | 58561 | 21% | 1% | 289 |
2 | Psychiatry | 25358 | 48% | 0% | 675 |
3 | Rehabilitation | 19374 | 25% | 0% | 344 |
4 | Psychology, Developmental | 14105 | 18% | 0% | 249 |
5 | Pediatrics | 4237 | 20% | 0% | 273 |
6 | Pharmacology & Pharmacy | 1481 | 21% | 0% | 291 |
7 | Psychology, Clinical | 565 | 5% | 0% | 69 |
8 | Clinical Neurology | 457 | 9% | 0% | 130 |
9 | Psychology, Educational | 142 | 1% | 0% | 20 |
10 | Neurosciences | 137 | 8% | 0% | 117 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHRISTIAN SARKINE AUTISM TREATMENT | 246903 | 1% | 59% | 19 |
2 | NISONGER | 168073 | 3% | 20% | 39 |
3 | NISONGER MENTAL RETARDAT DEV DISABIL | 131325 | 0% | 100% | 6 |
4 | NISONGER UCEDD | 88634 | 1% | 45% | 9 |
5 | MERCK PROGRAM | 70038 | 0% | 80% | 4 |
6 | WELSH LEARNING DISABIL CLIN STUDIES | 49245 | 0% | 75% | 3 |
7 | MENTAL IMPAIRMENT EVALUAT TREATMENT SERV | 43775 | 0% | 100% | 2 |
8 | SECT BRAIN MATURAT P050 | 43775 | 0% | 100% | 2 |
9 | SOURCE AUTISME HAUTE NORMANDIE | 43775 | 0% | 100% | 2 |
10 | WALLINGFORD CLIN | 43775 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 130593 | 6% | 7% | 87 |
2 | AMERICAN JOURNAL ON MENTAL RETARDATION | 62476 | 4% | 5% | 55 |
3 | JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS | 54612 | 7% | 3% | 96 |
4 | JOURNAL OF INTELLECTUAL DISABILITY RESEARCH | 36659 | 4% | 3% | 57 |
5 | JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 34525 | 6% | 2% | 88 |
6 | RESEARCH IN DEVELOPMENTAL DISABILITIES | 32642 | 5% | 2% | 68 |
7 | PSYCHOPHARMACOLOGY BULLETIN | 28126 | 3% | 3% | 48 |
8 | JOURNAL OF DEVELOPMENTAL AND PHYSICAL DISABILITIES | 20536 | 2% | 3% | 27 |
9 | BRITISH JOURNAL OF DEVELOPMENTAL DISABILITIES | 18956 | 1% | 6% | 14 |
10 | APPLIED RESEARCH IN MENTAL RETARDATION | 16479 | 1% | 6% | 12 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PERVASIVE DEVELOPMENTAL DISORDER | 112238 | 4% | 9% | 57 | Search PERVASIVE+DEVELOPMENTAL+DISORDER | Search PERVASIVE+DEVELOPMENTAL+DISORDER |
2 | MEDS | 100050 | 1% | 57% | 8 | Search MEDS | Search MEDS |
3 | PSYCHOTROPIC MEDICATION | 86369 | 2% | 14% | 29 | Search PSYCHOTROPIC+MEDICATION | Search PSYCHOTROPIC+MEDICATION |
4 | AUTISM | 76857 | 14% | 2% | 190 | Search AUTISM | Search AUTISM |
5 | AUTISTIC DISORDER | 68209 | 3% | 7% | 45 | Search AUTISTIC+DISORDER | Search AUTISTIC+DISORDER |
6 | RISPERIDONE | 58803 | 5% | 4% | 71 | Search RISPERIDONE | Search RISPERIDONE |
7 | INTELLECTUAL DISABILITY | 52381 | 8% | 2% | 107 | Search INTELLECTUAL+DISABILITY | Search INTELLECTUAL+DISABILITY |
8 | MENTAL RETARDATION | 49418 | 6% | 3% | 88 | Search MENTAL+RETARDATION | Search MENTAL+RETARDATION |
9 | ABERRANT BEHAVIOR CHECKLIST COMMUNITY | 43775 | 0% | 100% | 2 | Search ABERRANT+BEHAVIOR+CHECKLIST+COMMUNITY | Search ABERRANT+BEHAVIOR+CHECKLIST+COMMUNITY |
10 | ATOMOXETINE STRATTERA | 43775 | 0% | 100% | 2 | Search ATOMOXETINE+STRATTERA | Search ATOMOXETINE+STRATTERA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DOYLE, CA , MCDOUGLE, CJ , (2012) PHARMACOTHERAPY TO CONTROL BEHAVIORAL SYMPTOMS IN CHILDREN WITH AUTISM.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 13. ISSUE 11. P. 1615-1629 | 85 | 86% | 18 |
2 | MYERS, SM , (2007) THE STATUS OF PHARMACOTHERAPY FOR AUTISM SPECTRUM DISORDERS.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 8. ISSUE 11. P. 1579-1603 | 129 | 60% | 33 |
3 | ACCORDINO, RE , KIDD, C , POLITTE, LC , HENRY, CA , MCDOUGLE, CJ , (2016) PSYCHOPHARMACOLOGICAL INTERVENTIONS IN AUTISM SPECTRUM DISORDER.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 17. ISSUE 7. P. 937 -952 | 86 | 63% | 1 |
4 | POLITTE, LC , HENRY, CA , MCDOUGLE, CJ , (2014) PSYCHOPHARMACOLOGICAL INTERVENTIONS IN AUTISM SPECTRUM DISORDER.HARVARD REVIEW OF PSYCHIATRY. VOL. 22. ISSUE 2. P. 76 -92 | 91 | 58% | 16 |
5 | FARMER, CA , AMAN, MG , (2013) PHARMACOLOGICAL INTERVENTION FOR DISRUPTIVE BEHAVIORS IN INTELLECTUAL AND DEVELOPMENTAL DISABILITIES: THE GLASS IS HALF FULL.INTERNATIONAL REVIEW OF RESEARCH IN DEVELOPMENTAL DISABILITIES: CHALLENGING BEHAVIOR, VOL 44. VOL. 44. ISSUE . P. 281-325 | 76 | 78% | 2 |
6 | TAYLOR, LJ , (2016) PSYCHOPHARMACOLOGIC INTERVENTION FOR ADULTS WITH AUTISM SPECTRUM DISORDER: A SYSTEMATIC LITERATURE REVIEW.RESEARCH IN AUTISM SPECTRUM DISORDERS. VOL. 25. ISSUE . P. 58 -75 | 59 | 79% | 1 |
7 | POSEY, DJ , MCDOUGLE, CJ , (2000) THE PHARMACOTHERAPY OF TARGET SYMPTOMS ASSOCIATED WITH AUTISTIC DISORDER AND OTHER PERVASIVE DEVELOPMENTAL DISORDERS.HARVARD REVIEW OF PSYCHIATRY. VOL. 8. ISSUE 2. P. 45-63 | 87 | 80% | 56 |
8 | SUNG, M , FUNG, DSS , CAI, YM , OOI, YP , (2010) PHARMACOLOGICAL MANAGEMENT IN CHILDREN AND ADOLESCENTS WITH PERVASIVE DEVELOPMENTAL DISORDER.AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. VOL. 44. ISSUE 5. P. 410 -428 | 61 | 90% | 5 |
9 | VAHABZADEH, A , BUXTON, D , MCDOUGLE, CJ , STIGLER, KA , (2013) CURRENT STATE AND FUTURE PROSPECTS OF PHARMACOLOGICAL INTERVENTIONS FOR AUTISM.NEUROPSYCHIATRY. VOL. 3. ISSUE 2. P. 245-259 | 65 | 78% | 1 |
10 | LESKOVEC, TJ , ROWLES, BM , FINDLING, RL , (2008) PHARMACOLOGICAL TREATMENT OPTIONS FOR AUTISM SPECTRUM DISORDERS IN CHILDREN AND ADOLESCENTS.HARVARD REVIEW OF PSYCHIATRY. VOL. 16. ISSUE 2. P. 97 -112 | 71 | 72% | 31 |
Classes with closest relation at Level 1 |